eConsent

Our on demand webinar with Leanne Walsh from Northern Light Lifescience to dive into the process of eConsent adoption from sponsor to site.

Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.

In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models on the informed consent process.

Listen to our CEO & Founder, Derk Arts, as he reflects on lessons learned from the BIO panel discussion and what to expect at DIA.

As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD).

An avalanche of data from so many real-world sources is available today, with the promise of more data generated daily—so why not use it?

As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD).

Many researchers are still hesitant to adopt digital informed consent due to a misconception that digital forms are too complex. Listen to this month’s Download with Derk to hear his perspective on the topic.

Watch this webinar from ixlayer and Castor to find out where some of the hesitancy in running a decentralized clinical trial lies, and how to address these concerns to run a DCT effectively